Hansen Pharmaceutical(SZ:002412)2022-12-08 02:22Group 1: Company Overview and Strategy - The company focuses on traditional Chinese medicine and is expanding into health and rehabilitation sectors, emphasizing a combination of medical care and elderly care [3] - The health industry is a key development area for the company, with plans to integrate rehabilitation, health maintenance, and wellness [3][4] Group 2: Rehabilitation and Wellness Model - The company aims to create a high-end rehabilitation and wellness facility, differentiating itself from traditional nursing homes by offering more than just accommodation [4] - The chosen location for the facility is strategically placed between Yiyang and Changsha, providing convenient access and a pleasant environment [4] Group 3: Medical Partnerships and Resources - The company is targeting partnerships with secondary hospitals (Level II) and is open to collaborations with specialized departments and experts from major hospitals [5] - The company is developing a demonstration base for the cultivation of traditional Chinese medicinal herbs, focusing on resource integration rather than market monopoly [5] Group 4: Financial Investments and Risks - The company has invested over 400 million in the new South Yue Pharmaceutical plant, which has recently passed GMP certification [6] - Investment in Sanxiang Bank is aimed at supplementing profits and providing new financing channels, with funding sourced from internal funds and potential bank credit [6] Group 5: Market Performance and Sales Strategy - The market share of Si Mo Tang is currently 72% in OTC and grassroots medical institutions, while hospitals account for 28% [6] - The company has established a WeChat public account for brand promotion and is considering developing an app for direct sales in the future [6]